The cream, developed by researchers at the University of Santiago in Chile, is currently in the early stages of the testing.
It was applied to animals, and so far it has proved to be an effective solution for melanoma, said Sofia Michelson who, along with Claudio Acuna, led the research team.
"We are fighting melanoma because it is the most aggressive skin cancer. Other creams currently exist for treating skin cancer but they do not specifically treat this type," said Michelson.
The medication contains an extract of a shrub that is endemic in Chile. The substance affects the viability of the tumour cells, they said.
After applying the ointment on animals, the researchers were able to more than double the animals' life expectancy compared to other conventional medicines, the state-run 'Xinhua' news agency reported.
"The problem is that the human body does not react to tumours because they make bodies believe they are normal," Acuna said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
